Ofloxacine Viatris (Ofloxacin)

Ofloxacin is a fluoroquinolone antibiotic used to treat bacterial infections of the external ear.

• Otitis externa: Reduces bacterial load and alleviates inflammation in the ear canal.
• Other external ear infections: Provides antibacterial activity against susceptible organisms causing ear canal infections.
• Bacterial otitis media (off‑label): May be employed under specialist guidance for middle‑ear bacterial infections when topical therapy is appropriate.

• Ofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and transcription. By blocking these targets, it prevents bacterial cell division and leads to bacterial cell death, delivering a bactericidal effect against a broad spectrum of Gram‑negative and Gram‑positive organisms.

Ofloxacine Viatris may cause a range of adverse reactions, most of which are localized to the ear.

Common Side Effects

• Ear discomfort or burning sensation.
• Itching or mild pain in the treated ear.
• Transient hearing changes or muffled hearing.
• Local irritation or redness of the ear canal.
• Headache.
• Nausea.

Serious or Rare Side Effects

• Allergic reactions such as rash, swelling, or anaphylaxis.
• Severe ototoxicity leading to permanent hearing loss.
• Tendon rupture or tendonitis.
• Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Vision disturbances.
• Central nervous system effects such as seizures.

Before using Ofloxacine Viatris, consider the following safety measures.

• Allergy assessment: Verify no known hypersensitivity to fluoroquinolones.
• Indication confirmation: Use only for approved external ear infections.
• Duration limit: Avoid prolonged treatment beyond prescribed period.
• Tendon monitoring: Discontinue if tendon pain or swelling occurs.
• Concomitant ototoxic drugs: Use with caution when combined with other ototoxic agents.
• Store at room temperature: Keep in the original container, protect from moisture and light.

Ofloxacin can interact with several medicines; categorize them by clinical relevance.

Major Interactions (Avoid)

• Antacids or supplements containing magnesium or aluminum: Reduce absorption of ofloxacin.
• Warfarin: May increase anticoagulant effect and bleeding risk.
• Systemic corticosteroids: Heighten risk of tendon rupture.
• Theophylline: Potentially increase plasma theophylline concentrations.

Moderate Interactions (Monitor Closely)

• Non‑steroidal anti‑inflammatory drugs (NSAIDs): May increase tendon injury risk.
• Diabetic agents: May cause hypoglycemia.
• Other fluoroquinolones: Additive toxicity risk.
• Cyclosporine: Possible increase in cyclosporine levels.